ARCHIVES

Cancer Groups Endorse Richard Pazdur for Head of FDA’s New Office of Oncology Drug Products. Five Candidates Are In the Running for the Job, Sources Said.

This article is from The Cancer Letter archive.

Vol. 31 No. 07 | February 18, 2005

Download PDF Visit The Full Archive

Related Articles

DCE Board Approves Recompetitions, Program Announcement For Research On Fish

July 7, 1989

Slamon, Sherr Win Landon-AACR Prizes

March 7, 2003

Rep. Bliley Challenges FDA On Failure To Approve Oral Colon Cancer Drug UFT.

April 21, 2000

ACS President & COO Resigns Unexpectedly; Was Seen as Contender for CEO Position

December 19, 2014

In Brief: Deisseroth Leaves M.D. Anderson To Head Yale’s Oncology, Gene Therapy Programs

September 15, 1995

Majority of Invasive Bladder Cancer Patients Do Not Receive Full Recommended Care

August 26, 2011